Brief: Orthofix Medical Q4 Gross Margin 68.2%
05/03/2024 21:03
Mar 05 (Reuters) - Orthofix Medical Q4 adjusted EBITDA USD 20 million
Recent news on Orthofix Medical
See all newsOrthofix Medical Inc. reports results for the quarter ended June 30 - Earnings Summary
Orthofix Medical Q2 sales slightly beat estimates
Orthofix Medical Inc expected to post a loss of 41 cents a share - Earnings Preview
Orthofix Medical Q1 sales beat estimates, reaffirms FY outlook
Brief: Orthofix Medical Inc - Announces Strategic Realignment Of Spine Leadership Team